RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRC
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

AtriCure stock price down 0.489% on Tuesday
(Updated on Jul 02, 2024)

Sell candidate since Jul 01, 2024 Loss -0.49% PDF

The AtriCure stock price fell by -0.489% on the last day (Tuesday, 2nd Jul 2024) from $22.50 to $22.39. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.32% from a day low at $21.96 to a day high of $22.69. The price has fallen in 6 of the last 10 days but is still up by 12.74% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -35 thousand shares and in total, 865 thousand shares were bought and sold for approximately $19.36 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.90% during the next 3 months and, with a 90% probability hold a price between $17.05 and $20.58 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRC Signals & Forecast

The AtriCure stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $22.47. On a fall, the stock will find some support from the long-term average at approximately $22.26. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 20, 2024, and so far it has fallen -5.79%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for AtriCure stock

AtriCure finds support from accumulated volume at $22.22 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.730 between high and low, or 3.32%. For the last week, the stock has had daily average volatility of 5.27%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRC) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect AtriCure to open at $22.35, and during the day (based on 14 day Average True Range), to move between $21.07 and $23.71, which gives a possible trading interval of +/-$1.32 (+/-5.91%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 11.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $22.22 (0.76%) than the resistance at $22.77 (1.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is AtriCure stock A Buy?

AtriCure holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.661 Sell Candidate Unchanged

Predicted Opening Price for AtriCure of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$22.35 ( 0.194%) $22.39

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRC

Fibonacci Support & Resistance Levels

Level Price
R3 23.08 3.07%
R2 22.80 1.82%
R1 22.63 1.05%
Price 22.39
S1 22.07 -1.44%
S2 21.90 -2.21%
S3 21.62 -3.45%

Accumulated Volume Support & Resistance Levels

Level Price
R3 23.77 6.14%
R2 22.94 2.46%
R1 22.77 1.70%
Price 22.39
S1 22.22 -0.759%
S2 22.10 -1.30%
S3 21.20 -5.31%

FAQ

What is the symbol for AtriCure Stock and on which exchange is it traded?
The symbol for AtriCure is ATRC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AtriCure Stock?
AtriCure holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy AtriCure Stock?
AtriCure Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AtriCure Stock.

What's the current price of AtriCure Stock?
As of the end of day on the Jul 02, 2024, the price of an AtriCure (ATRC) share was $22.39.

What is the 52-week high and low for AtriCure Stock?
The 52-week high for AtriCure Stock is $59.61 and the 52-week low is $18.94.

What is the market capitalization of AtriCure Stock?
As of the Jul 02, 2024, the market capitalization of AtriCure is 1.089B.

When is the next earnings date for AtriCure?
The upcoming earnings date for AtriCure is Jul 23, 2024.
Click to get the best stock tips daily for free!

About AtriCure

AtriCure AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem... ATRC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT